New local anaesthetics - How much is improved safety worth? [1]

Acta Anaesthesiologica Scandinavica

Volumn 45, Issue 5, 2001, Pages 652-653

  Wildsmith, J A W ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPIVACAINE; LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; ROPIVACAINE;

CARDIOTOXICITY; CONVULSION; COST BENEFIT ANALYSIS; DRUG SAFETY; HEART ARREST; HEART ARRHYTHMIA; LETTER; OBSTETRIC ANESTHESIA; PRIORITY JOURNAL;

EID: 0035020503     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2001.045005652.x     Document Type: Letter

References (26)

1. Are the new local anesthetics worth their cost?
2. Is ropivacaine less potent than bupivacaine?
3. A comparison of epidural analgesia with 0.125% ropivacaine with fentanyl versus 0.125% bupivacaine with fentanyl during labor
4. Potency, impotency, and importance!
5. Cardiac arrest following regional anesthesia with etidocaine or bupivacaine
6. max)
7. Cardiotoxicity of ropivacaine - A new amide local anaesthetic agent
8. Comparison of the direct cardiotoxicity of the isomers of ropivacaine and bupivacaine
9. Comparison of the effects of bupivacaine and ropivacaine on heart cell mitochondrial bioenergetics
10. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine
11. Systolic functional effects of racemic bupivacaine (B), levobupivacaine (L) and ropivacaine (R): An experimental study in anaesthetized swine
12. Acute toxicity of ropivacaine compared with that of bupivacaine
13. Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
14. Is bupivacaine cardiotoxicity an electrophysiologic phenomenon?
15. Regional anesthesia and local anesthetic-induced systemic toxicity: Seizure frequency and accompanying cardiovascular changes
16. Serious complications related to regional anesthesia
17. Accidental iv injections of ropivacaine: Clinical experiences of six cases
18. Neonatal outcome and mode of delivery after epidural analgesia for labour with ropivacaine and bupivacaine: A prospective meta-analysis
19. A double-blind comparison of 0.125% ropivacaine with sufentanil and 0.125% bupivacaine with sufentanil for epidural labor analgesia
20. Ambulatory labor epidural analgesia: Bupivacaine versus ropivacaine
21. Ropivacaine, 0.1%, plus sufentanil, 0.5 μg/ml, versus bupivacaine, 0.1%, plus sufentanil, 0.5 μg/ml, using patient-controlled epidural analgesia for labor
22. Epidural analgesia with local anesthetics after abdominal surgery: Earlier motor recovery with 0.2% ropivacaine than 0.175% bupivacaine
23. Neonatal adaptation after caesarean section: A comparison between ropivacaine and bupivacaine
24. Fewer neonatal adverse events after caesarean section in epidural anaesthesia with ropivacaine in comparison to bupivacaine